Skip to main content

Table 6 Characteristics, risk factors, and diagnostic and therapeutic procedures for all cardiovascular events combined (acute coronary syndrome, stroke, aortic aneurysm and dissection or acute lower limb ischemia) admissions in type 2 diabetes mellitus (T2DM) versus non-diabetic patients, according to year of study (2002, 2006, 2010, and 2014)

From: Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002–2014)

 

2002

2006

2010

2014

T2DM

No T2DM

p value

T2DM

No T2DM

p value

T2DM

No T2DM

p value

T2DM

No T2DM

p value

N (%)a,b

27,255 (100)

27,255 (100)

NA

32,252 (100)

32,252 (100)

NA

35,098 (100)

35,098 (100)

NA

35,406 (100)

35,406 (100)

NA

Age adjusted rate per 100.000 inhabitantsa

142.1

NA

NA

153.6

NA

NA

153.91

NA

NA

145.13

NA

NA

Male sex, n (%)a,b

16,677 (61.19)

16,677 (61.19)

NA

20,265 (62.83)

20,265 (62.83)

NA

22,168 (63.16)

22,168 (63.16)

NA

22,558 (63.71)

22,558 (63.71)

NA

Age, mean (SD)a,b

72.03 (10.35)

72.03 (10.35)

NA

72.56 (10.95)

72.56 (10.95)

NA

72.93 (11.44)

72.93 (11.44)

NA

73.19 (11.8)

73.19 (11.8)

NA

40–59 years, n (%)

3616 (13.27)

3616 (13.27)

NA

4503 (13.96)

4503 (13.96)

NA

5137 (14.64)

5137 (14.64)

NA

5381 (15.2)

5381 (15.2)

NA

60–69 years, n (%)

6270 (23)

6270 (23)

6607 (20.49)

6607 (20.49)

7153 (20.38)

7153 (20.38)

7359 (20.78)

7359 (20.78)

70–79 years, n (%)

10,649 (39.07)

10,649 (39.07)

11,738 (36.39)

11,738 (36.39)

11,328 (32.28)

11,328 (32.28)

10,022 (28.31)

10,022 (28.31)

≥ 80 years, n (%)

6720 (24.66)

6720 (24.66)

9404 (29.16)

9404 (29.16)

11,480 (32.71)

11,480 (32.71)

12,644 (35.71)

12,644 (35.71)

CCI, mean (SD)a,b

2.56 (0.79)

1.49 (0.74)

< 0.01

2.64 (0.84)

1.54 (0.79)

< 0.01

2.68 (0.86)

1.58 (0.82)

< 0.01

2.79 (0.9)

1.69 (0.86)

< 0.01

Smoking, n (%)a,b

5393 (19.79)

6014 (22.07)

< 0.01

8101 (25.12)

9129 (28.31)

< 0.01

9768 (27.83)

10,894 (31.04)

< 0.01

10,480 (29.6)

11,857 (33.49)

< 0.01

Obesity, n (%)a,b

1737 (6.37)

964 (3.54)

< 0.01

2852 (8.84)

1552 (4.81)

< 0.01

3933 (11.21)

2157 (6.15)

< 0.01

4651 (13.14)

2551 (7.2)

< 0.01

Hypertension, n (%)a,b

14,449 (53.01)

11,428 (41.93)

< 0.01

20,005 (62.03)

15,844 (49.13)

< 0.01

22,471 (64.02)

17,963 (51.18)

< 0.01

22,523 (63.61)

18,344 (51.81)

< 0.01

Lipid metabolism disorders, n (%)a,b

2574 (9.44)

1740 (6.38)

< 0.01

6176 (19.15)

4238 (13.14)

< 0.01

11,461 (32.65)

8012 (22.83)

< 0.01

14,818 (41.85)

10,010 (28.27)

< 0.01

Renal diseases, n (%)a,b

1872 (6.87)

1272 (4.67)

< 0.01

2924 (9.07)

1899 (5.89)

< 0.01

4250 (12.11)

2638 (7.52)

< 0.01

5284 (14.92)

3427 (9.68)

< 0.01

Atrial fibrillation, n (%)a,b

4002 (14.68)

4464 (16.38)

< 0.01

5483 (17)

5749 (17.83)

0.003

6707 (19.11)

6958 (19.82)

0.009

7426 (20.97)

7588 (21.43)

0.098

CHF, n (%)

3605 (13.23)

2985 (10.95)

< 0.01

4347 (13.48)

3323 (10.3)

< 0.01

4792 (13.65)

3763 (10.72)

< 0.01

4871 (13.76)

3759 (10.62)

< 0.01

Mechanical ventilation, n (%)

872 (3.2)

923 (3.39)

0.209

1014 (3.14)

1061 (3.29)

0.281

1025 (2.92)

1227 (3.5)

< 0.01

1105 (3.12)

1270 (3.59)

< 0.01

HD/DP, n (%)a,b

181 (0.66)

140 (0.51)

0.022

286 (0.89)

190 (0.59)

< 0.01

328 (0.93)

244 (0.70)

< 0.01

399 (1.13)

249 (0.70)

< 0.01

CABG, n (%)b

222 (0.81)

222 (0.81)

0.905

229 (0.71)

213 (0.66)

0.439

249 (0.71)

241 (0.69)

0.714

242 (0.68)

214 (0.6)

0.188

PCI, n (%)a,b

2046 (7.51)

2361 (8.66)

< 0.01

4184 (12.97)

4597 (14.25)

< 0.01

5715 (16.28)

6118 (17.43)

< 0.01

6679 (18.86)

7130 (20.14)

< 0.01

Fibrinolysis, n (%)a,b

1659 (6.09)

1762 (6.46)

0.046

1432 (4.44)

1727 (5.35)

< 0.01

1554 (4.43)

2027 (5.78)

< 0.01

1350 (3.81)

1869 (5.28)

< 0.01

Decompressive craniectomy, n (%)a,b

32 (0.12)

32 (0.12)

0.603

29 (0.09)

37 (0.11)

0.326

47 (0.13)

71 (0.2)

0.028

56 (0.16)

84 (0.24)

0.017

Carotid endarterectomy, n (%)a,b

38 (0.14)

47 (0.17)

0.318

37 (0.11)

59 (0.18)

0.026

94 (0.27)

77 (0.22)

0.184

93 (0.26)

83 (0.23)

0.446

Carotid angioplasty, n (%)a,b

0 (0)

0 (0)

NA

31 (0.1)

26 (0.08)

0.501

68 (0.19)

105 (0.3)

0.005

129 (0.36)

154 (0.43)

0.131

Thoracic aorta aneurysm open surgery, n (%)a,b

9 (0.03)

9 (0.03)

0.913

23 (0.07)

33 (0.1)

0.127

25 (0.07)

50 (0.14)

0.001

45 (0.13)

51 (0.14)

0.460

TEVAR, n (%)b

0 (0)

0 (0)

NA

0 (0)

0 (0)

NA

25 (0.07)

16 (0.05)

0.133

37 (0.1)

33 (0.09)

0.600

Abdominal aorta aneurysm open surgery, n (%)

87 (0.32)

96 (0.35)

0.406

112 (0.35)

114 (0.35)

0.881

100 (0.28)

135 (0.38)

0.011

137 (0.39)

156 (0.44)

0.204

EVAR, n (%)a,b

20 (0.07)

22 (0.08)

0.758

95 (0.29)

78 (0.24)

0.145

234 (0.67)

194 (0.55)

0.019

314 (0.89)

293 (0.83)

0.253

Minor amputation, n (%)a,b

585 (2.15)

356 (1.31)

< 0.01

626 (1.94)

333 (1.03)

< 0.01

646 (1.84)

345 (0.98)

< 0.01

652 (1.84)

383 (1.08)

< 0.01

Major amputation, n (%)a,b

594 (2.18)

623 (2.29)

0.337

624 (1.93)

599 (1.86)

0.396

568 (1.62)

544 (1.55)

0.416

500 (1.41)

538 (1.52)

0.183

Lower extremity revascularization, n (%)a,b

1016 (3.73)

950 (3.49)

0.076

1064 (3.3)

1014 (3.14)

0.209

952 (2.71)

1032 (2.94)

0.038

852 (2.41)

990 (2.8)

< 0.01

Lower extremity angioplasty, n (%)a,b

378 (1.39)

351 (1.29)

0.289

624 (1.93)

507 (1.57)

< 0.01

1077 (3.07)

840 (2.39)

< 0.01

1456 (4.11)

1144 (3.23)

< 0.01

LHS, mean (SD)a,b

12.41 (13.28)

11.87 (13.65)

< 0.01

11.51 (12.92)

10.87 (13.21)

< 0.01

10.44 (13.22)

10.22 (14.28)

0.030

9.1 (10.52)

9.08 (11.11)

0.837

In-hospital mortality, n (%)a,b

3555 (13.04)

3464 (12.71)

0.226

4002 (12.41)

3909 (12.12)

0.242

4134 (11.78)

4066 (11.58)

0.402

3814 (10.77)

3728 (10.53)

0.269

  1. CCI charlson comorbidity index, CHF congestive heart failure, HD/DP hemodyalisis/peritoneal dialysis, CABG coronary artery bypass graft, PCI percutaneous coronary intervention, TEVAR endovascular implantation of graft in thoracic aorta, EVAR endovascular implantation of graft in abdominal aorta, LHS length of hospital stay
  2. aSignificant time trend among T2DM sufferers
  3. bSignificant time trend among non-T2DM sufferers